DaVita Inc. $DVA Shares Acquired by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management increased its DaVita stake by 30.5% in the second quarter, acquiring 10,477 additional shares and bringing its holdings to 44,783 shares valued at approximately $9.96 million. Institutional investors collectively own 90.12% of the company.
• DaVita reported quarterly earnings of $4.02 per share, exceeding analyst expectations of $3.88, while revenue rose 5.2% year over year to $3.55 billion. The company guided for fiscal 2026 EPS of $14.10 to $15.20.
• Analyst sentiment remains mixed: DaVita has an average “Hold” rating and a consensus price target of $221.75, despite UBS raising its target to $270 and Truist cutting its target to $215.

Assenagon Asset Management S.A. increased its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 30.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,783 shares of the company's stock after acquiring an additional 10,477 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.07% of DaVita worth $9,963,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Invesco Ltd. grew its holdings in shares of DaVita by 2.0% during the third quarter. Invesco Ltd. now owns 1,679,248 shares of the company's stock worth $223,122,000 after buying an additional 32,358 shares during the last quarter. Morgan Stanley lifted its position in DaVita by 5.1% during the 4th quarter. Morgan Stanley now owns 1,477,045 shares of the company's stock worth $167,807,000 after acquiring an additional 71,156 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in shares of DaVita by 114.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company's stock valued at $135,196,000 after purchasing an additional 636,191 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of DaVita by 5.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,145,436 shares of the company's stock valued at $176,037,000 after purchasing an additional 56,336 shares during the last quarter. Finally, LSV Asset Management increased its holdings in shares of DaVita by 1.1% in the fourth quarter. LSV Asset Management now owns 936,768 shares of the company's stock valued at $106,426,000 after purchasing an additional 9,739 shares during the period. Hedge funds and other institutional investors own 90.12% of the company's stock.

DaVita Stock Performance

DVA opened at $183.42 on Tuesday. The business's fifty day moving average is $218.29 and its two-hundred day moving average is $177.59. The company has a market cap of $11.70 billion, a price-to-earnings ratio of 15.01, a PEG ratio of 0.61 and a beta of 0.88. DaVita Inc. has a one year low of $101.00 and a one year high of $247.49.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share for the quarter, beating the consensus estimate of $3.88 by $0.14. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The company had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.50 billion. During the same quarter in the prior year, the company earned $2.95 earnings per share. DaVita's revenue was up 5.2% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, analysts predict that DaVita Inc. will post 14.57 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on DVA shares. UBS Group increased their price target on DaVita from $235.00 to $270.00 and gave the stock a "buy" rating in a report on Friday, July 10th. Barclays upped their price objective on shares of DaVita from $218.00 to $224.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 5th. Truist Financial reduced their target price on shares of DaVita from $250.00 to $215.00 and set a "hold" rating for the company in a research note on Friday. Oppenheimer set a $220.00 price target on shares of DaVita in a research note on Friday. Finally, Weiss Ratings raised shares of DaVita from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, August 5th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $221.75.

Insider Transactions at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 15,405 shares of the company's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the sale, the insider owned 109,194 shares of the company's stock, valued at $22,756,029.60. This represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.90% of the company's stock.

About DaVita

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source